135 related articles for article (PubMed ID: 38361107)
1. Review: Are moles senescent?
Bennett DC
Pigment Cell Melanoma Res; 2024 May; 37(3):391-402. PubMed ID: 38361107
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes.
Ruiz-Vega R; Chen CF; Razzak E; Vasudeva P; Krasieva TB; Shiu J; Caldwell MG; Yan H; Lowengrub J; Ganesan AK; Lander AD
Elife; 2020 Oct; 9():. PubMed ID: 33047672
[TBL] [Abstract][Full Text] [Related]
3. Melanocytic Nevi and the Genetic and Epigenetic Control of Oncogene-Induced Senescence.
Huang JM; Chikeka I; Hornyak TJ
Dermatol Clin; 2017 Jan; 35(1):85-93. PubMed ID: 27890240
[TBL] [Abstract][Full Text] [Related]
4. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.
Fan T; Jiang S; Chung N; Alikhan A; Ni C; Lee CC; Hornyak TJ
Mol Cancer Res; 2011 Apr; 9(4):418-29. PubMed ID: 21383005
[TBL] [Abstract][Full Text] [Related]
5. Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression.
Soo JK; Mackenzie Ross AD; Kallenberg DM; Milagre C; Heung Chong W; Chow J; Hill L; Hoare S; Collinson RS; Hossain M; Keith WN; Marais R; Bennett DC
Pigment Cell Melanoma Res; 2011 Jun; 24(3):490-503. PubMed ID: 21418545
[TBL] [Abstract][Full Text] [Related]
6. Melanocytic nevi and melanoma: unraveling a complex relationship.
Damsky WE; Bosenberg M
Oncogene; 2017 Oct; 36(42):5771-5792. PubMed ID: 28604751
[TBL] [Abstract][Full Text] [Related]
7. Senescence-Like Phenotypes in Human Nevi.
Joselow A; Lynn D; Terzian T; Box NF
Methods Mol Biol; 2017; 1534():175-184. PubMed ID: 27812879
[TBL] [Abstract][Full Text] [Related]
8. Human nevi: no longer precursors of melanomas?
Zhang G; Herlyn M
J Invest Dermatol; 2012 Sep; 132(9):2133-4. PubMed ID: 22895446
[TBL] [Abstract][Full Text] [Related]
9. Genetics of melanocytic nevi.
Roh MR; Eliades P; Gupta S; Tsao H
Pigment Cell Melanoma Res; 2015 Nov; 28(6):661-72. PubMed ID: 26300491
[TBL] [Abstract][Full Text] [Related]
10. Absence of distinguishing senescence traits in human melanocytic nevi.
Tran SL; Haferkamp S; Scurr LL; Gowrishankar K; Becker TM; Desilva C; Thompson JF; Scolyer RA; Kefford RF; Rizos H
J Invest Dermatol; 2012 Sep; 132(9):2226-34. PubMed ID: 22513787
[TBL] [Abstract][Full Text] [Related]
11. A murine model for the development of melanocytic nevi and their progression to melanoma.
Nasti TH; Cochran JB; Tsuruta Y; Yusuf N; McKay KM; Athar M; Timares L; Elmets CA
Mol Carcinog; 2016 May; 55(5):646-58. PubMed ID: 25788145
[TBL] [Abstract][Full Text] [Related]
12. Melanocytic nevi and tumor progression: perspectives concerning histomorphology, melanoma risk and molecular genetics.
Barnhill RL
Dermatology; 1993; 187(2):86-90. PubMed ID: 8358111
[TBL] [Abstract][Full Text] [Related]
13. Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression.
Kohli J; Ge C; Fitsiou E; Doepner M; Brandenburg SM; Faller WJ; Ridky TW; Demaria M
Nat Commun; 2022 Dec; 13(1):7923. PubMed ID: 36564381
[TBL] [Abstract][Full Text] [Related]
14. Assessment of clonality in melanocytic nevi.
Hui P; Perkins A; Glusac E
J Cutan Pathol; 2001 Mar; 28(3):140-4. PubMed ID: 11168766
[TBL] [Abstract][Full Text] [Related]
15. New and evolving concepts of melanocytic nevi and melanocytomas.
Yeh I
Mod Pathol; 2020 Jan; 33(Suppl 1):1-14. PubMed ID: 31659277
[TBL] [Abstract][Full Text] [Related]
16. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer.
Bastian BC
Oncogene; 2003 May; 22(20):3081-6. PubMed ID: 12789284
[TBL] [Abstract][Full Text] [Related]
17. Molecular Genomic Profiling of Melanocytic Nevi.
Colebatch AJ; Ferguson P; Newell F; Kazakoff SH; Witkowski T; Dobrovic A; Johansson PA; Saw RPM; Stretch JR; McArthur GA; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Waddell N; Scolyer RA; Wilmott JS
J Invest Dermatol; 2019 Aug; 139(8):1762-1768. PubMed ID: 30772300
[TBL] [Abstract][Full Text] [Related]
18. Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas.
Richmond A; Fine R; Murray D; Lawson DH; Priest JH
J Invest Dermatol; 1986 Mar; 86(3):295-302. PubMed ID: 3745955
[TBL] [Abstract][Full Text] [Related]
19. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs.
Zhu G; Duffy DL; Eldridge A; Grace M; Mayne C; O'Gorman L; Aitken JF; Neale MC; Hayward NK; Green AC; Martin NG
Am J Hum Genet; 1999 Aug; 65(2):483-92. PubMed ID: 10417291
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.
Vredeveld LC; Possik PA; Smit MA; Meissl K; Michaloglou C; Horlings HM; Ajouaou A; Kortman PC; Dankort D; McMahon M; Mooi WJ; Peeper DS
Genes Dev; 2012 May; 26(10):1055-69. PubMed ID: 22549727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
